← All Precision Biosciences INC filings

Precision Biosciences INC Form 4 insider transactions

NASDAQ
DTIL
Precision Biosciences INC
Form 4: Precision BioSciences CEO Michael Amoroso Reports Acquisition of Restricted Stock Units
Michael Amoroso, CEO of Precision BioSciences, reports the acquisition of 111,217 restricted stock units.
NASDAQ
DTIL
Precision Biosciences INC
Form 4: Precision BioSciences Executive Dario Scimeca Awarded Restricted Stock Units
Dario Scimeca, General Counsel and Secretary of Precision BioSciences, was granted 25,277 restricted stock units (RSUs) on April 18, 2024, vesting annually starting January 20, 2025.
NASDAQ
DTIL
Precision Biosciences INC
Form 4: Precision BioSciences CFO John Alexander Kelly Reports Acquisition of Restricted Stock Units
Chief Financial Officer of Precision BioSciences, John Alexander Kelly, reports the acquisition of 41,705 restricted stock units.